Peripheral artery disease treatment: Paclitaxel-coated devices under watch - Medical Device Network

Peripheral artery disease treatment: Paclitaxel-coated devices under watch  Medical Device Network

Peripheral artery disease treatment: FDA found that people being treated with paclitaxel-coated devices for PAD were at increased risk of mortality.



Comments

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management